查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571887

心血管和软组织修復贴片的全球市场

Cardiovascular and Soft Tissue Repair Patches
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球心血管和软组织修復补片市场预计将达到 83 亿美元

心血管和软组织修復补片的全球市场预计 2023 年为 51 亿美元，预计到 2030 年将达到 83 亿美元，2023-2030 年分析期间复合年增长率为 7.4%。 ePTFE 原料是本报告分析的细分市场之一，预计复合年增长率为 7.2%，到分析期结束时将达到 50 亿美元。分析期内，生物材料和组织工程材料领域的复合年增长率预计为 7.9%。

美国市场预计13亿美元，中国预计复合年增长率11.1%

预计2023年美国心血管软组织修復补片市场规模将达13亿美元。中国作为世界第二大经济体，预计2030年市场规模将达20亿美元，2023-2030年分析期间复合年增长率为11.1%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 3.7% 和 6.7%。在欧洲，德国的复合年增长率预计为 4.4%。

全球心血管和软组织修復贴片市场 - 主要趋势和驱动因素总结

为什么心血管和软组织修復补片对现代医学至关重要？

心血管和软组织修復补片是用于修復体内受损组织和结构的重要医疗设备，特别是在心血管手术和重组手术中。这些贴片由合成或生物材料製成，旨在促进组织癒合、支撑薄弱区域并恢復器官和组织的结构完整性。在心血管应用中，用于治疗先天性心臟缺陷、动脉瘤、瓣膜性心臟病等。在软组织修復中，它对于疝气修復、腹壁重组和其他创伤相关损伤至关重要。

由于心血管疾病（CVD）盛行率的增加以及与组织修復相关的外科手术数量的增加，心血管和软组织修復补片的需求显着增加。随着手术技术和材料的进步，这些补片为患者提供了更可靠、更持久的解决方案，促进更快的康復和更好的结果。此外，在贴片开发中使用生物相容性和生物可吸收材料可以增强身体的自然癒合过程，并减少感染疾病和免疫反应等併发症。这些贴片在现代医学中变得至关重要，因为它们能够支持患者的长期康復并减少再次手术的可能性。

科技进步如何形塑心血管和软组织修復补片市场？

技术进步正在彻底改变心血管和软组织修復补片市场，提高其有效性、耐用性和生物相容性。一项重要的进步是仿生贴片的使用。这些贴片通常由胶原蛋白或其他生物支架製成，融入患者体内并随着时间的推移逐渐吸收，促进自然组织再生。这降低了排斥的风险并改善了治癒效果。此外，使用在组织癒合后溶解的生物可吸收材料消除了重新手术去除贴片的需要，提高了患者的舒适度并降低了医疗成本。

另一个重大进步是开发了具有更高耐用性和机械强度的合成补片。聚合物科学的创新已经开发出能够承受高机械应力的贴片，使其适合在心臟等动态环境中使用。结合了生物和合成成分的混合贴片也越来越受欢迎，因为它们具有两种材料的优点：促进组织生长，同时提供结构支撑。此外，3D 列印和奈米技术正在成为客製化补片生产的变革性工具，使外科医生能够根据患者的个别需求精确地客製化补片的形状和尺寸。

哪些医疗和消费趋势正在推动对心血管和软组织修復贴片的需求？

一些医疗和消费趋势正在影响对心血管和软组织修復补片的需求，特别是慢性病盛行率的增加和对微创手术的日益重视。由于人口老化以及肥胖和高血压等生活方式因素，心血管疾病的发生率不断增加，导致全球心血管手术数量显着增加。心血管补片对于治疗各种心臟疾病至关重要，包括先天缺陷、动脉瘤和受损的心臟瓣膜，从而创造了这些医疗设备的稳定需求。此外，创伤相关损伤以及针对疝气和软组织断裂等疾病的重组手术的增加增加了对可靠软组织修復解决方案的需求。

推动需求的另一个主要趋势是人们越来越偏好微创手术，因为微创手术可以提供更快的恢復时间和更少的併发症。软组织修补补片，特别是那些为腹腔镜手术设计的补片，在微创疝气修补和腹部手术中越来越受欢迎。现今的患者更加意识到微创治疗的好处，并寻求能够更快恢復和缓解疼痛的手术。用于此类手术的先进、灵活、生物可吸收贴片的开发符合这种微创选择的需求。此外，人们对感染疾病和补片失败等术后併发症的认识不断提高，促使外科医生和医疗保健提供者选择高品质、高度生物相容性的材料来改善患者的治疗效果。对减少手术併发症和提高患者满意度的重视正在推动心血管和软组织修復补片的设计和功能创新。

心血管和软组织修復补片市场的成长受到多种因素的推动。

心血管和软组织修復补片市场的成长受到多种因素的推动，包括心血管和软组织疾病发病率的增加、补片材料和设计的进步以及对微创手术解决方案的需求不断增加。主要驱动因素之一是全球心血管疾病负担不断增加，心血管疾病仍是全球第一大死因。动脉瘤、先天性心臟疾病和瓣膜性心臟病等疾病的手术数量不断增加，推动了对心血管修復补片的需求，特别是那些具有改善的生物相容性和耐用性的补片。

生物工程和合成贴片材料的技术进步也是市场成长的重要因素。生物可吸收贴片和混合材料等创新结合了生物和合成成分的最佳特性，使这些设备对患者更有效、更安全。此外，可根据患者独特的解剖学需求量身定制的 3D 列印贴片的开拓正在扩大个人化医疗设备市场。对微创手术技术的日益关注进一步推动了市场的发展。软组织修补补片，特别是用于腹腔镜疝气修补手术的补片，需求量很大，因为它们可以缩短恢復时间并最大限度地减少疤痕。随着医疗保健提供者越来越多地采用微创方法，对灵活、易于使用和高效能贴片的需求预计将会成长。此外，先进医疗基础设施的不断扩大和新兴市场医疗保健支出的增加正在为市场扩张创造新的机会。随着全球医疗保健系统继续优先考虑创新、安全和以患者为中心的护理，心血管和软组织修復补片市场有望持续成长。

受访企业范例（共42家）

  • Abbott（St Jude Medical）
  • Admedus
  • Atriummed
  • B.Braun
  • Bard Peripheral Vascular, Inc.
  • Baxter
  • CorMatrix
  • Cryolife, Inc.
  • Edwards Life Sciences Corporation
  • GETINGE Group
  • Glycar SA Pty Ltd.
  • Gunze Limited
  • LabCor
  • LeMaitre Vascular Inc.
  • Maverick Bioscience
  • Medtronic
  • Neovasc
  • Novomedics
  • Perouse Medical
  • Southern Lights Biomaterials
  • TEI Biosciences Inc.
  • Terumo Medical Corporation
  • WL Gore & Associates, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP21438

Global Cardiovascular and Soft Tissue Repair Patches Market to Reach US$8.3 Billion by 2030

The global market for Cardiovascular and Soft Tissue Repair Patches estimated at US$5.1 Billion in the year 2023, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. ePTFE Raw Material, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$5.0 Billion by the end of the analysis period. Growth in the Biomaterial & Tissue Engineered Material segment is estimated at 7.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 11.1% CAGR

The Cardiovascular and Soft Tissue Repair Patches market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Cardiovascular and Soft Tissue Repair Patches Market – Key Trends & Drivers Summarized

Why Are Cardiovascular and Soft Tissue Repair Patches Essential in Modern Medicine?

Cardiovascular and soft tissue repair patches are critical medical devices used to repair damaged tissues and structures within the body, particularly in cardiac surgeries and reconstructive procedures. These patches, made from either synthetic or biological materials, are designed to facilitate tissue healing, support weakened areas, and restore the structural integrity of organs and tissues. In cardiovascular applications, they are used to treat conditions like congenital heart defects, aneurysms, and valvular diseases. For soft tissue repair, these patches are essential in hernia repairs, abdominal wall reconstruction, and other trauma-related injuries.

The demand for cardiovascular and soft tissue repair patches has risen significantly due to the increasing prevalence of cardiovascular diseases (CVDs) and the growing number of surgical procedures related to tissue repair. With advancements in surgical techniques and materials, these patches provide a more reliable, durable solution for patients, promoting faster recovery and better outcomes. Furthermore, the use of biocompatible and bioresorbable materials in patch development enhances the body's natural healing processes, reducing complications such as infections or immune reactions. These patches have become indispensable in modern medicine for their ability to support long-term patient recovery and reduce the likelihood of surgical re-intervention.

How Are Technological Advancements Shaping the Cardiovascular and Soft Tissue Repair Patches Market?

Technological advancements are revolutionizing the cardiovascular and soft tissue repair patches market, improving their effectiveness, durability, and biocompatibility. One significant development is the use of bioengineered patches, which are designed to mimic the body’s natural tissues. These patches, often derived from collagen or other biological scaffolds, promote natural tissue regeneration by integrating into the patient’s body and gradually being absorbed over time. This reduces the risk of rejection and improves healing outcomes. Additionally, the use of bioresorbable materials that dissolve after the tissue has healed eliminates the need for follow-up surgeries to remove the patches, improving patient comfort and reducing healthcare costs.

Another major advancement is the development of synthetic patches with enhanced durability and mechanical strength. Innovations in polymer science have led to the creation of patches that can withstand high mechanical stresses, making them suitable for use in dynamic environments such as the heart. Hybrid patches, which combine both biological and synthetic components, are also gaining popularity as they offer the benefits of both materials, providing structural support while encouraging tissue growth. Furthermore, 3D printing and nanotechnology are emerging as transformative tools in the production of customized patches, allowing surgeons to tailor the shape and size of patches to fit individual patient needs precisely.

What Medical and Consumer Trends Are Driving the Demand for Cardiovascular and Soft Tissue Repair Patches?

Several medical and consumer trends are shaping the demand for cardiovascular and soft tissue repair patches, particularly the increasing prevalence of chronic diseases and the growing emphasis on minimally invasive procedures. The rise in cardiovascular diseases, driven by aging populations and lifestyle factors like obesity and hypertension, has significantly increased the number of cardiac surgeries worldwide. Cardiovascular patches are critical in treating a variety of heart conditions, including congenital defects, aneurysms, and damaged heart valves, creating a steady demand for these medical devices. Additionally, the rise in trauma-related injuries and the growing number of reconstructive surgeries for conditions like hernias and soft tissue tears have driven the need for reliable soft tissue repair solutions.

Another major trend driving demand is the growing preference for minimally invasive surgeries, which result in shorter recovery times and fewer complications. Soft tissue repair patches, especially those designed for laparoscopic procedures, have become increasingly popular in minimally invasive hernia repairs and abdominal surgeries. Patients today are more aware of the benefits of less invasive treatments and are seeking procedures that offer quicker recovery and reduced pain. The development of advanced, flexible, and bioresorbable patches that can be used in these types of surgeries is aligning with this demand for minimally invasive options. Moreover, the increasing awareness of postoperative complications, such as infections and patch failure, is prompting surgeons and healthcare providers to choose high-quality, biocompatible materials that improve patient outcomes. The emphasis on reducing surgical complications and enhancing patient satisfaction is fostering innovation in the design and functionality of cardiovascular and soft tissue repair patches.

Growth in the Cardiovascular and Soft Tissue Repair Patches Market Is Driven by Several Factors

Growth in the cardiovascular and soft tissue repair patches market is driven by several factors, including the increasing incidence of cardiovascular and soft tissue disorders, advancements in patch materials and design, and the rising demand for minimally invasive surgical solutions. One of the primary drivers is the growing global burden of cardiovascular diseases, which remains the leading cause of death worldwide. The increasing number of surgeries for conditions such as aneurysms, congenital heart defects, and valvular diseases is driving the demand for cardiovascular repair patches, particularly those that offer improved biocompatibility and durability.

Technological advancements in bioengineered and synthetic patch materials are another significant factor contributing to market growth. Innovations such as bioresorbable patches and hybrid materials that combine the best properties of biological and synthetic components are making these devices more effective and safer for patients. Additionally, the development of 3D-printed patches, which can be customized to match a patient’s specific anatomical needs, is expanding the market for personalized medical devices. The rising focus on minimally invasive surgical techniques is further boosting the market. Soft tissue repair patches, especially those used in laparoscopic surgeries for hernia repairs, are in high demand due to their ability to reduce recovery times and minimize scarring. As healthcare providers increasingly adopt minimally invasive approaches, the demand for flexible, easy-to-use, and high-performance patches is expected to grow. Moreover, the expanding availability of advanced healthcare infrastructure and rising healthcare spending in emerging markets are opening new opportunities for market expansion. As the global healthcare system continues to prioritize innovation, safety, and patient-centered care, the cardiovascular and soft tissue repair patches market is poised for sustained growth.

Select Competitors (Total 42 Featured) -

  • Abbott (St Jude Medical)
  • Admedus
  • Atriummed
  • B.Braun
  • Bard Peripheral Vascular, Inc.
  • Baxter
  • CorMatrix
  • Cryolife, Inc.
  • Edwards Life Sciences Corporation
  • GETINGE Group
  • Glycar SA Pty Ltd.
  • Gunze Limited
  • LabCor
  • LeMaitre Vascular Inc.
  • Maverick Bioscience
  • Medtronic
  • Neovasc
  • Novomedics
  • Perouse Medical
  • Southern Lights Biomaterials
  • TEI Biosciences Inc.
  • Terumo Medical Corporation
  • W.L. Gore & Associates, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cardiovascular and Soft Tissue Repair Patches - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Biomaterials and Biotechnology Drive Innovations in Cardiovascular and Soft Tissue Repair Patches
    • Increasing Incidences of Cardiovascular Diseases Worldwide Propel the Use of Repair Patches in Surgeries
    • Growth in Minimally Invasive Surgical Techniques Boosts Demand for Cardiovascular Patches
    • Innovations in Drug-Eluting and Bioactive Patches Enhance Healing and Functional Integration
    • Rising Demand for Durable and Biocompatible Soft Tissue Repair Solutions
    • Development of Synthetic and Natural Patches to Meet Diverse Clinical Needs
    • Expansion of Treatment Indications for Repair Patches Beyond Cardiovascular Applications
    • Consumer Awareness and Surgeon Advocacy Play Crucial Roles in the Adoption of New Patch Technologies
    • Technological Enhancements in Imaging and Placement Techniques for Precision in Patch Application
    • Market Trends Toward Customizable and Patient-Specific Repair Patch Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for ePTFE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Biomaterial & Tissue Engineered Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Biomaterial & Tissue Engineered Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Biomaterial & Tissue Engineered Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Soft Tissue Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cardiac Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cardiac Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Cardiac Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Vascular Repair & Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Vascular Repair & Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Vascular Repair & Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Pericardial Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Pericardial Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Pericardial Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Dural Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Dural Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Dural Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Cardiovascular and Soft Tissue Repair Patches Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030

IV. COMPETITION